Home › Funds › SG Americas Securities, LLC › ABBV

SG Americas Securities, LLC position in ABBV

ABBVIE INC · Health Care

SG Americas Securities, LLC reported holding 3,984,924 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$1.00B, representing 0.57% of its reported portfolio and ranking #26 among its reported holdings. SG Americas Securities, LLC has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.98M sh
Reported value held$1.00B
Portfolio Weight0.57%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SG Americas Securities, LLC's ABBV position evolved

SG Americas Securities, LLC first disclosed a stake in ABBV in Q3 2023 at 390,360 shares (US$36.9M). The position peaked in Q2 2026 at 3,984,924 shares, worth US$1.00B. Across 12 filings, SG Americas Securities, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,984,924 shares valued at US$1.00B — an increase of 2,789,663 shares quarter over quarter.. Notable position changes include a 169% increase in Q4 2023 (shares rose 19% over the following quarter), a 68% increase in Q2 2025 (shares rose 26% over the following quarter), a 233% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 390.36K $36.85M New
Q4 2023 1.05M $124.06M Add
Q1 2024 682.36K $89.90M Reduce
Q2 2024 376.73K $42.21M Reduce
Q3 2024 156.46K $4.90M Reduce
Q4 2024 230.08K $17.45M Add
Q1 2025 313.02K $24.20M Add
Q2 2025 524.47K $80.34M Add
Q3 2025 473.38K $61.02M Reduce
Q4 2025 724.79K $119.42M Add
Q1 2026 1.20M $247.17M Add
Q2 2026 3.98M $1.00B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has SG Americas Securities, LLC held ABBV?

SG Americas Securities, LLC has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SG Americas Securities, LLC's current position in ABBV?

As of Q2 2026, SG Americas Securities, LLC holds 3.98M shares of ABBV (ABBVIE INC), valued at $1.00B, representing 0.57% of its reported portfolio and ranking #26.

Has SG Americas Securities, LLC been buying or selling ABBV?

In the latest 13F filing (Q2 2026), SG Americas Securities, LLC increased its position in ABBV. The position peaked in Q2 2026 at 3.98M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.